Switch to:
Sanofi SA (NYSE:SNY)
Cash from Financing
$-3,923 Mil (TTM As of Jun. 2016)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jun. 2016, Sanofi SA paid $1,558 Mil more to buy back shares than it received from issuing new shares. It received $1,192 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $4,224 Mil paying cash dividends to shareholders. It spent $10 Mil on other financial activities. In all, Sanofi SA spent $4,600 Mil on financial activities for the six months ended in Jun. 2016.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Sanofi SA's Cash from Financing for the fiscal year that ended in Dec. 2015 is calculated as:

Cash from Financing(A: Dec. 2015 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1318.08278867+1466.23093682+0+-4023.96514161+-46.8409586057
=-3,923

Sanofi SA's Cash from Financing for the quarter that ended in Jun. 2016 is

Cash from Financing(Q: Jun. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1558.42696629+1192.13483146+0+-4223.59550562+-10.1123595506
=-4,600

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sanofi SA Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2016 was $-3,923 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Sanofi SA's net issuance of stock for the six months ended in Jun. 2016 was $-1,558 Mil. Sanofi SA paid $1,558 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Sanofi SA's net issuance of debt for the six months ended in Jun. 2016 was $1,192 Mil. Sanofi SA received $1,192 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Sanofi SA's net issuance of preferred for the six months ended in Jun. 2016 was $0 Mil. Sanofi SA paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Sanofi SA's cash flow for dividends for the six months ended in Jun. 2016 was $-4,224 Mil. Sanofi SA spent $4,224 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Sanofi SA's other financing for the six months ended in Jun. 2016 was $-10 Mil. Sanofi SA spent $10 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi SA Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Net Issuance of Stock 471-2,201-1,581245-325-1,317-232-871-1,381-1,318
Net Issuance of Debt -5,497-1,361932,803-1,5426,951-807822-4641,466
Net Issuance of Preferred 0000000000
Dividends -2,697-3,454-3,659-4,195-4,151-1,805-13-4,990-4,533-4,024
Other Financing -10-0-00-128-22-4,657-71-10-47
Cash from Financing -7,733-7,016-5,147-1,147-6,1473,807-5,710-5,111-6,387-3,923

Sanofi SA Semi-Annual Data

Dec11Jun12Dec12Jun13Dec13Jun14Dec14Jun15Dec15Jun16
Net Issuance of Stock -1,207-477266-197-667-1,049-429-877-467-1,558
Net Issuance of Debt -8,057784-1,627359449156-605-6402,0871,192
Net Issuance of Preferred 0000000000
Dividends 14-4,3754,563-4,81112-8-4,525-4,1460-4,224
Other Financing -22-36-4,619-1-70-4,9954,523-17-31-10
Cash from Financing -9,271-4,104-1,417-4,650-276-5,895-1,037-5,6791,589-4,600
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK